Category: Advocacy

February 3, 2026

New Federal Momentum for HHT: $3M for Centers and Dedicated Research Eligibility

We are thrilled to share two major wins to celebrate today: the President has signed the FY26 funding agreement which includes $3,000,000 for HHT…

The world’s leading patient advocacy organization for hereditary hemorrhagic telangiectasia (HHT). We work to find, treat, and cure it.

Cure HHT on Facebook
Cure HHT on Instagram
Cure HHT on LinkedIn
Cure HHT on YouTube

Sign up for our newsletter

Accreditation and membership

Cure HHT provides information to educate patients, caregivers, and healthcare professionals about HHT. Content on this website is developed with input from qualified medical professionals and is periodically updated to reflect advancements in research and clinical care.

The medical information on this website is for general informational and educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Decisions regarding the care and treatment of HHT or any other medical condition should always be made in consultation with a physician or other qualified healthcare provider.

PO Box 329, Monkton, MD 21111

Privacy Policy

Terms of Use

Category: Advocacy

New Federal Momentum for HHT: $3M for Centers and Dedicated Research Eligibility